Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Best Practices for Pharmacists to Optimize Use of Obesity Treatment Options and Overcome Barriers to Care

In this podcast episode, Drs Megan Adelman and Elizabeth Pogge review obesity treatment options, with a focus on injectable therapies and overcoming barriers to care.
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Released: April 22, 2022

In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.

Information on this Educational Activity

Faculty

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Megan Adelman, PharmD, BCPS, BCGP, CDCES, has no relevant conflicts of interest to report.
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA

Professor 
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Expert faculty insight on evidence for finerenone use in DKD, selecting patients for therapy, overcoming clinical inertia, from ProCE

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: April 29, 2022 Expired: April 28, 2023

Expert faculty provide practical strategies for successful implementation of digital techonologies to improve diabetes outcomes from ProCE

Andrew Bzowyckyi, PharmD, BCPS, CDCES Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: April 18, 2022 Expired: April 17, 2023

Downloadable slides featuring expert insight on obesity, including guideline recommendations and a review of available pharmacotherapy, from ProCE

Released: April 12, 2022

Downloadable slides featuring expert insight on obesity, including guideline recommendations and a review of available pharmacotherapy, from ProCE

Released: April 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings